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December 20101734 AbstractsMethods: One hundred fifty-three mesenteric ischemia patients had
both DUS and arteriography. ROC curves were used to analyze PSV, EDV,
and SMA or CA/aortic PSV ratio in detecting significant st.
Results: For SMA (151 arteries; 67 with 50%, 30 50%, 54 70% st.
based on angiography): Themost accurate PSVs for detecting50% and70%
st. were295 cm/s and400 cm/s with a sensitivity (sens.) of 87% and 72%,
specificity (spec.) 89% and 93%, PPV91% and 84%, andNPV84% and 85%, and
overall accuracy (OA) 88% and 85%, respectively. If Moneta’s criteria were
applied (PSV 275 cm/s for 70% st.) in our series, the sens., spec., PPV, NPV
andOAwere 92%, 59%, 56%, 93%, and 71%, respectively.When a PSVof300
cm/s (Bowersox for 50% st.) was applied, the sens., spec., PPV, NPV, and OA
were 86%, 89%, 91%, 83%, and 87%, respectively. Meanwhile, an EDV of45
cm/s (Zwolak) and70 cm/s (Perko) had a sens. of 79% and 47%, spec. 79%
and 98%, PPV 84% and 97%, NPV 72% and 57%, and OA 79% and 68% for
50% st., respectively. ROCanalysis showed that PSVwas better thanEDVand
SMA/aortic PSV ratio for50% st. of SMA and CA (P .003 and P .0005,
and P  .00001 and P  .04, respectively, Figs 1 and 2). For celiac arteries
(150 arteries; 45 with 50%, 43 50%, and 62 70% st.): The most
accurate PSVs for 50% and 70% st. were 240 cm/s and 320 cm/s
with sens. of 88% and 80%, spec. 83% and 89%, PPV 93% and 84%, NPV 74%
and 86%, and OA 87% and 85%, respectively. If Moneta’s criteria were
applied (PSV  200 cm/s for 70% st.), sens., spec., PPV, NPV, and OA
were 98%, 35%, 52%, 97%, and 61%, respectively.When a PSV of300 cm/s
(Bowersox) was applied, the sens., spec., PPV, NPV, and OA were 72%,
95%, 97%, 59%, and 79% for 50% stenosis. Meanwhile, an EDV of 45
cm/s (Zwolak) and 70 cm/s (Perko) had a sens. of 80% and 62%, spec.
58% and 88%, PPV 82% and 92%, NPV 53% and 49%, and OA 73% and 70%
for 50% st., respectively.
Conclusions: PSV values can be used in detecting significant SMA/CA
stenosis and were better than EDVs and ratios in detecting 50% st. of SMA
and CA. Previously published data must be validated in individual vascular labs.Impact of Metabolic Syndrome on SFA Interventions
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Background: Metabolic syndrome (Met Syn) is an epidemic in the
United States and is associated with early onset of atherosclerosis, increased
thrombotic events and increased complications after cardiovascular inter-
vention. Met Syn is found in 50% of patients with peripheral vascular
disease however its impact on peripheral interventions is unknown. The aim
of this study is to determine the outcomes of superficial femoral artery (SFA)
interventions in patients with and without metabolic syndrome.
Methods: A database of patients undergoing endovascular treatment
of the SFA arteries between 1999 and 2009 was retrospectively queried.Met
Syn was defined as the presence of 3 of the following criteria: Blood
pressure 130 mmHg/ 85 mmHg; Triglycerides 150 mg/dL; HDL
 50 mg/dL for women and  40 mg/dL for men; Fasting blood glucose
 110 mg/dL; or body mass index (BMI)  30 kg/m2. Kaplan-Meier
survival analyses were performed to assess time-dependent outcomes. Factor
analyses were performed using a Cox proportional hazard model for time
dependent variables.
Results: One thousand fourteen limbs in 870 patients (64% male)
(average age 67 years) underwent endovascular treatment for symptomatic
SFA disease. Forty six percent met the criteria for Met Syn. Met Syn patients
were more likely to be female and to present with critical ischemia (rest
pain/tissue loss) and have more advanced TASC II SFA lesions (Table).
Mortality was equivalent but morbidity was higher in the Met Syn group.
The presence of Met Syn was associated with a decrease in clinical efficacy as
determined by freedom from recurrent symptoms, decreased primary pa-
tency, and an increase in major amputations (Table).
No Met Syn Met Syn P value
Number limbs at risk (n) 542 464 -
Male gender (%) 69 56 .001
Claudication (%) 62 46 .001
Rest pain/tissue loss (%) 38 54
TASC-II C and D lesions (%) 31 51 .001
30-day mortality (%) 1.3 0.2 .08
Morbidity (%) 9 14 .03
5-y freedom from recurrent symptoms (%) 73 67 .03
5-y primary patency (%) 66 56 .008
5-y assisted primary patency (%) 78 71 .06
5-y secondary patency (%) 78 71 .12
5-y limb salvage rate 87 78 .02
Conclusions: Met Syn is present in nearly half of patients presenting
with SFA disease. These patients present with more advanced disease and
have poorer symptomatic and functional outcomes compared to those
patients without Met Syn. Met Syn should be considered a risk factor for
poor outcomes during SFA interventions.
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Background: To investigate surgical site infection (SSI) statistics after
arterial interventions requiring a groin incision (a known risk factor for SSI);
including the influence of therapeutic vs prophylactic antibiotics, medical
comorbidities associated with SSI, causative microbiology, and treatment
outcomes.
Methods:A 1-year (2009) retrospective, consecutive-case audit of 372
lower limb arterial interventions (bypass grafting, n 236; AAA, stent graft,
n  86; endarterectomy/repair, n  50) requiring a groin incision. Occur-
rence of SSI within 30 days was correlated with age, gender, body mass
index, procedural therapeutic (active infection at time of procedure) vs
prophylactic (24 hours) antibiotic administration, medical comorbidities
(diabetes, renal insufficiency, coronary artery disease), and the presence of
methicillin-resistant Staphylococcus aureus (MRSA) nasal colonization. In
the prophylactic patient group (n  311), the effect of adding an MRSA
antibiotic (vancomycin, 15-20 mg/kg - 2 doses; daptomycin, 6 mg/kg -
1-dose) to cephalosporin prophylaxis on SSI rate was analyzed.
Results: The overall SSI rate was 15%; higher (P  .001) in patients
receiving therapeutic (29%; 18 of 61) vs prophylactic (12%; 38 of 311)
antibiotics. Nasal MRSA colonization was associated with2 increase in SSI
(37% vs 16%; P  .01). SSI was lowest after open/EVAR AAA repair (5%)
compared to arterial bypass (21%) or endarterectomy/repair (20%) proce-
dures. The majority (64%) of SSIs were caused by gram  bacteria with
MRSA isolated from 37% of all positive cultures. The SSI rate in patients
receiving prophylactic antibiotics was 19% in the cephalosporin (cefazolin or
